Acute exacerbations of COPD in subjects completing pulmonary rehabilitation

Chest

Volumn 132, Issue 1, 2007, Pages 127-134

  Carr, S Jocelyn ^a   Goldstein, Roger S ^a   Brooks, Dina ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Department of Physical Therapy ^*  (Canada)

Author keywords

6 min walk test; Acute exacerbation; COPD; Health related quality of life; Pulmonary rehabilitation

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; EXERCISE TOLERANCE; FATIGUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUALITY OF LIFE; WALKING;

EID: 34447526858     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-0269     Document Type: Article

References (51)

1. Celli BR, MacNee W, Agusti A, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932-946
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: executive summary; 2006. Available at: http://www.goldcopd.org. Accessed January 12, 2007
3. Morgan MDL, Calverley PMA, Clark CJ, et al. British Thoracic Society statement: pulmonary rehabilitation. Thorax 2001; 56:827-834
4. O'Donnell DE, Aaron S, Bourbeau J, et al. State of the art compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease. Can Respir J 2004; 11(suppl):7B-59B
5. Lacasse Y, Maltais F, Goldstein RS. Pulmonary rehabilitation: an integral part of the long-term management of COPD. Swiss Med Wkly 2004; 134:601-605
6. Cambach W, Chadwick-Straver RV, Wagenaar RC, et al. The effects of a community-based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. Eur Respir J 1997; 10:104-113
7. Troosters T, Gosselink R, Decramer M. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med 2000; 109:207-212
8. Brooks D, Krip B, Mangovski-Alzamora S, et al. The effect of post-rehabilitation programs among individuals with COPD. Eur Respir J 2002; 20:1-10
9. Ries AL, Make BJ, Lee SM, et al. The effects of pulmonary rehabilitation in the national emphysema treatment trial. Chest 2005; 128:3799-3809
10. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbation of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106:196-220
11. Pauwels RA, Buist AS, Calverley PMA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD); workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276
12. Seemungal TAR, Donaldson GC, Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:4608-1613
13. Wedzicha JA. Airway infection accelerates decline of lung function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164:1757-1760
14. Wedzicha JA. Exacerbations: etiology and pathophysiologic mechanisms. Chest 2002; 121(suppl):136S-141S
15. Garcia-Aymerich J, Farrero E, Felez MA, et al. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58:100-105
16. American Association of Cardiovascular and Pulmonary Rehabilitation, American College of Chest Physicians, Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines; ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. Chest 1997; 112:1363-1396
17. ATS/ERS Pulmonary Rehabilitation Writing Committee. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173:1390-1413
18. Man WD-C, Polkey MI, Donaldson N, et al. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ 2004; 329:1209-1212
19. Puhan MA, Scharplatz M, Troosters T, et al. Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality, a systematic review. Respir Res 2005; 6:54
20. Decramer M, Gosselink R, Troosters T, et al. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 1997; 10:417-423
21. Carr SJ, Brooks D, Goldstein RS. Influence of abbreviated pulmonary rehabilitation on exercise capacity following an acute exacerbation of COPD. J Cardiopulm Rehabil (in press)
22. Lacasse Y, Wong E, Guyatt G. A systematic overview of the measurement properties of the Chronic Respiratory Questionnaire. Can Respir J 1997; 4:131-139
23. Lacasse Y, Wong E, Guyatt G, et al. Health status measurement instruments in chronic obstructive pulmonary disease. Can Respir J 1997; 4:152-164
24. Guyatt GH, Berman LB, Townsend M, et al. A measure of quality of life for clinical trial in chronic lung disease. Thorax 1987; 42:773-778
25. American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111-117
26. Guyatt GH, Pugsley SO, Sullivan MJ, et al. Effect of encouragement on walking test performance. Thorax 1984; 39:818-822
27. Redelmeier DA, Bayoumi AM, Goldstein RS, et al. Interpreting small differences in functional status: the six-minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997; 155:1278-1282
28. Solway S, Brooks D, Lacasse Y, et al. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001; 119:256-270
29. Garrod R, Bestall JC, Paul EA, et al. Development and validation of a standardized measure of activities of daily living in patients with severe COPD: the London Chest Activity of Daily Living Scale (LCADL). Respir Med 2000; 94:589-596
30. Bennett KJ, Torrance GW. Measuring health state preferences and utilities: rating scale, time trade-off, and standard gamble techniques. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers, 1996
31. Baldasarre FG, Arthur HM, Dicenso A, et al. Effect of coronary artery bypass graft surgery on older women's health-related quality of life. Heart Lung 2002; 31:421-431
32. Schunemann HJ, Goldstein RS, Mador MJ, et al. A randomized trial to evaluate the self-administered standardized chronic respiratory questionnaire. Eur Respir J 2005; 25: 31-40
33. Nava S. Rehabilitation of patients admitted to a respiratory intensive care unit. Arch Phys Med Rehabil 1998; 79:849-854
34. Kirsten DK, Taube C, Lehnigk B, et al. Exercise training improves recovery in patients with COPD after an acute exacerbation. Respir Med 1998; 92:1191-1198
35. Aaron SD, Vandemheen KL, Clinch JJ, et al. Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation. Chest 2002; 121:688-696
36. Wilkinson TMA, Donaldson GC, Hurst JR, et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 169:1298-1303
37. Donaldson GC, Wilkinson TMA, Hurst JR, et al. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171:446-452
38. Kessler R, Faller M, Fourgaut G, et al. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159:158-164
39. Lacasse Y, Brosseau L, Milne S, et al. Pulmonary rehabilitation for chronic obstructive lung disease. Cochrane Database Syst Rev (database online). Issue 4, 2004
40. Lacasse Y, Wong E, Guyatt GH, et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996; 348:1115-1119
41. Foglio K, Bianchi L, Bruletti G, et al. Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. Eur Respir J 1999; 13:125-132
42. Murphy N, Bell C, Costello RW. Extending a home from hospital care programme for COPD exacerbations to include pulmonary rehabilitation. Respir Med 2005; 99:1297-1302
43. Calverley PM, Boonsawat W, Cseke Z, et al. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J 2003; 22:912-919
44. Szafranski W, Cukier A, Ramirez A, et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive lung disease. Eur Respir J 2003; 21:74-81
45. Jones PW, Willits LR, Burge PS, et al. Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations. Eur Respir J 2003; 21: 68-73
46. Burge PS, Calverley PMA, Jones PW, et al. Randomised, double blind, placebo controlled study of fluticasone propi-onate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320:1297-1303
47. Lorig KR, Ritter PH, Stewart P, et al. Chronic disease self-management program: 2-year health status and health care utilization outcomes. Med Care 2001; 39:1217-1223
48. Watson PB, Town GI, Holbrook N, et al. Evaluation of a self-management plan for chronic obstructive pulmonary disease. Eur Respir J 1997; 10:1267-1271
49. Turnock AC, Walters EH, Walters JA, et al. Action plans for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (database online). Issue 4, 2005
50. Bourbeau J, Julien M, Maltais F, et al. A disease specific self-management intervention reduces hospital use in patients with chronic obstructive pulmonary disease. Arch Intern Med 2003; 163:585-591
51. Cote CG, Dordelly LJ, Celli BR. Impact of COPD Exacerbations on Patient-centered outcomes. Chest 2007; 131:696-704